Neonatal hypoxic-ischemic encephalopathy (HIE) is an important cause of mortality and
morbidity in the perinatal period. This condition results from a period of ischemia and …

The brain is one of the main organs affected by hypoxia and reoxygenation in the neonatal
period and one of the most vulnerable to oxidative stress. Hypoxia/ischemia and …

Recently, stem cells have been considered renewable cell sources in the treatment of
diabetes and the development of insulin-producing cells. In this regard, the current study …

Perinatal brain injury (PBI) in preterm birth is associated with substantial injury and
dysmaturation of white and gray matter, and can lead to severe neurodevelopmental deficits …

Mesenchymal stem/stromal cells (MSCs) have demonstrated efficacy in pre-clinical models
of inflammation and tissue injury, including in models of lung injury and infection. Rolling …

Perinatal hypoxic ischemic encephalopathy (HIE) results in serious neurological dysfunction
and mortality. Clinical trials of multilineage-differentiating stress enduring cells (Muse cells) …

Stem cells have been used for regenerative and therapeutic purposes in a variety of
diseases. In ischemic brain injury, preclinical studies have been promising, but have failed …

Neonatal necrotizing enterocolitis (NEC) is a serious disease of premature infants that
necessitates intensive care and frequently results in life-threatening complications and high …

Mesenchymal stromal cells (MSCs) are administered locally to treat sites of inflammation.
Local delivery is known to cause MSCs to aggregate into “spheroids,” which alters gene …

Human bone marrow-derived mesenchymal stem/stromal cells (hMSCs) have shown
potential in facilitating recovery from spinal cord injury (SCI) through communicating with …